GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phaarmasia Ltd (BOM:523620) » Definitions » Cyclically Adjusted PS Ratio

Phaarmasia (BOM:523620) Cyclically Adjusted PS Ratio : 0.67 (As of Jun. 04, 2025)


View and export this data going back to 1992. Start your Free Trial

What is Phaarmasia Cyclically Adjusted PS Ratio?

As of today (2025-06-04), Phaarmasia's current share price is ₹27.00. Phaarmasia's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was ₹40.46. Phaarmasia's Cyclically Adjusted PS Ratio for today is 0.67.

The historical rank and industry rank for Phaarmasia's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:523620' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.56   Med: 0.86   Max: 1.63
Current: 0.67

During the past years, Phaarmasia's highest Cyclically Adjusted PS Ratio was 1.63. The lowest was 0.56. And the median was 0.86.

BOM:523620's Cyclically Adjusted PS Ratio is ranked better than
80.62% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs BOM:523620: 0.67

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Phaarmasia's adjusted revenue per share data for the three months ended in Dec. 2024 was ₹6.886. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹40.46 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Phaarmasia Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Phaarmasia's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phaarmasia Cyclically Adjusted PS Ratio Chart

Phaarmasia Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.75 0.96 0.65 0.76

Phaarmasia Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 0.76 1.41 1.38 1.20

Competitive Comparison of Phaarmasia's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Phaarmasia's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phaarmasia's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phaarmasia's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Phaarmasia's Cyclically Adjusted PS Ratio falls into.


;
;

Phaarmasia Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Phaarmasia's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=27.00/40.46
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phaarmasia's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Phaarmasia's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=6.886/158.3229*158.3229
=6.886

Current CPI (Dec. 2024) = 158.3229.

Phaarmasia Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 4.750 97.163 7.740
201506 3.048 99.841 4.833
201509 6.246 101.753 9.718
201512 4.618 102.901 7.105
201603 5.138 102.518 7.935
201606 5.736 105.961 8.571
201609 4.325 105.961 6.462
201612 8.393 105.196 12.632
201703 8.725 105.196 13.131
201706 8.002 107.109 11.828
201709 5.229 109.021 7.594
201712 10.757 109.404 15.567
201803 7.573 109.786 10.921
201806 6.031 111.317 8.578
201809 5.728 115.142 7.876
201812 7.304 115.142 10.043
201903 18.428 118.202 24.683
201906 12.295 120.880 16.103
201909 5.908 123.175 7.594
201912 10.924 126.235 13.701
202003 6.410 124.705 8.138
202006 7.638 127.000 9.522
202009 6.461 130.118 7.862
202012 7.585 130.889 9.175
202103 7.793 131.771 9.363
202106 5.762 134.084 6.804
202109 7.750 135.847 9.032
202112 5.691 138.161 6.522
202203 6.072 138.822 6.925
202206 7.947 142.347 8.839
202209 9.873 144.661 10.805
202212 11.685 145.763 12.692
202303 10.840 146.865 11.686
202306 10.107 150.280 10.648
202309 12.767 151.492 13.343
202312 7.481 152.924 7.745
202403 14.576 153.035 15.080
202406 12.000 155.789 12.195
202409 8.683 157.882 8.707
202412 6.886 158.323 6.886

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Phaarmasia  (BOM:523620) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Phaarmasia Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Phaarmasia's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Phaarmasia Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 16, Phase III, IDA, Jeedimetla, Hyderabad, TG, IND, 500055
Phaarmasia Ltd is a pharmaceutical company based in India. It is engaged in the manufacturing of Oral Contraceptive Pills and Combipack with Iron tablets. It offers hormone and herbal products. The company operates in one operating segment namely, Manufacturing and sale of OCPs, and derives prime revenue from India.

Phaarmasia Headlines

No Headlines